Literature DB >> 12792230

Current management of purpura fulminans: a multicenter study.

P M Warner1, R J Kagan, K P Yakuboff, N Kemalyan, T L Palmieri, D G Greenhalgh, R L Sheridan, D W Mozingo, D M Heimbach, N S Gibran, L Engrav, J R Saffle, L S Edelman, G D Warden.   

Abstract

Seven burn centers performed a 10-yr retrospective chart review of patients diagnosed with purpura fulminans. Patient demographics, etiology, presentation, medical and surgical treatment, and outcome were reviewed. A total of 70 patients were identified. Mean patient age was 13 yr. Neisseria meningitidis was the most common etiologic agent in infants and adolescents whereas Streptococcus commonly afflicted the adult population. Acute management consisted of antibiotic administration, volume resuscitation, ventilatory and inotropic support, with occasional use of corticosteroids (38%) and protein C replacement (9%). Full-thickness skin and soft-tissue necrosis was extensive, requiring skin grafting and amputations in 90% of the patients. One fourth of the patients required amputations of all extremities. Fasciotomies when performed early appeared to limit the level of amputation in 6 of 14 patients. Therefore, fasciotomies during the initial management of these patients may reduce the depth of soft-tissue involvement and the extent of amputations.

Entities:  

Mesh:

Year:  2003        PMID: 12792230     DOI: 10.1097/01.BCR.0000066789.79129.C2

Source DB:  PubMed          Journal:  J Burn Care Rehabil        ISSN: 0273-8481


  11 in total

1.  Delayed Surgical Debridement and Use of Semiocclusive Dressings for Salvage of Fingers After Purpura Fulminans.

Authors:  Paula A Pino; Javier A Román; Felipe Fernández
Journal:  Hand (N Y)       Date:  2016-08-03

2.  [Treatment failure after postinfectious purpura fulminans despite interdisciplinary surgical and intensive medical therapy].

Authors:  S A Alawi; R Ipaktchi; K Suchodolski; A Jokuszies
Journal:  Med Klin Intensivmed Notfmed       Date:  2020-02-13       Impact factor: 0.840

3.  Purpura fulminans in meningococcal septicaemia in an adult: a case report.

Authors:  D Bollero; M Stella; E N Gangemi; L Spaziante; J Nuzzo; G Sigaudo; F Enrichens
Journal:  Ann Burns Fire Disasters       Date:  2010-03-31

4.  Two cases of meningococcal purpura fulminans: the 'less is more' approach.

Authors:  Zeeshan Ahmad; Robert Jordan; Rana Das-Gupta; Shekhar Srivastava
Journal:  Int Wound J       Date:  2013-01-17       Impact factor: 3.315

5.  Sepsis-induced purpura fulminans caused by Pasteurella multocida.

Authors:  Lisa Borges; Nelson Oliveira; Isabel Cássio; Humberto Costa
Journal:  BMJ Case Rep       Date:  2014-02-19

6.  Refractory gram-negative septic shock complicated by extended purpura fulminans and multiple organ failure in a 23-year-old puerpera -a case report.

Authors:  Dmitriy Viderman; Yerlan Umbetzhanov; Talgat Temirov; Vsevolod V Kuzkov
Journal:  Korean J Anesthesiol       Date:  2020-07-21

7.  Successful Corticosteroid Treatment for Purpura Fulminans Associated with Quinolone.

Authors:  Ikue Okamura; Yukitsugu Nakamura; Yuka Katsurada; Ken Sato; Takashi Ikeda; Fumihiko Kimura
Journal:  Intern Med       Date:  2016-10-15       Impact factor: 1.271

Review 8.  Surgical outcomes in adults with purpura fulminans: a systematic review and patient-level meta-synthesis.

Authors:  Kevin M Klifto; Caresse F Gurno; Michael J Grzelak; Stella M Seal; Mohammed Asif; C Scott Hultman; Julie A Caffrey
Journal:  Burns Trauma       Date:  2019-10-18

Review 9.  Septic Shock and Purpura Fulminans Due to Streptococcus pneumoniae Bacteremia in an Unvaccinated Immunocompetent Adult: Case Report and Review.

Authors:  Nikola Djurdjevic; Pahnwat Tonya Taweesedt; Margaret Paulson; Abigail LaNou; Milan Radovanovic; Janki N Patel; Mladjen Veselinovic; Wendy R McDermott; Igor Dumic
Journal:  Am J Case Rep       Date:  2020-06-09

10.  Sepsis-induced digital ischaemia in a professional pianist, in the absence of vasopressors.

Authors:  Vishnu Kurup; R Scott Simpson
Journal:  BMJ Case Rep       Date:  2019-10-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.